Formoterol + glycopyrronium + budesonide (Trixeo aerosphere)

Status:
Grey
Decision Date:
June 2021
 

Comments

GREY (Trixeo aerosphere, MDI):

Indicated for the maintenance treatment of moderate to severe COPD.

Triple therapy is reserved for exceptional use in severe disease in the presence of persistent exacerbations despite other treatments.

Triple therapy in a single inhaler may be preferable for people who have difficulty using more than one device or who find their medication regimen difficult or confusing, and have trouble complying with treatment. However triple therapy lack flexibility and makes it difficult to amend the individual medicines if treatment needs changing for any reason.

Use of this combination product is cheaper than using the separate components.

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app